Evaluating how cationic lipid affects mRNA-LNP physical properties and biodistribution
European Journal of Pharmaceutics and Biopharmaceutics · 2024-02 · 195 · 114077
DOI: 10.1016/j.ejpb.2023.08.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2024-02. Verfasst von Claire Guéguen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Polyplus, 75 rue Marguerite Perey, 67400 Illkirch-Graffenstaden, France. Hauptthemen laut MEDLINE: Lipids, Nanoparticles. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
RNA therapeutics represents a powerful strategy for diseases where other approaches have failed, especially given the recent successes of mRNA vaccines against the coronavirus disease 2019 (COVID-19) and small interfering (siRNA) therapeutics. However, further developments are still required to reduce toxicity, improve stability and biodistribution of mRNA-LNPs (lipid nanoparticles). Here, we show a rational combinatorial approach to select the best formulation based on a new cationic lipid molecule (IM21.7c), which includes an imidazolium polar head. The study allowed us to select the optimal 5 lipids composition for in vivo mRNA delivery. IM21.7c based mRNA-LNPs measuring less than 100 nm had high encapsulation efficiency, protected mRNA from degradation, and exhibited sustained release kinetics for effective in vitro transfection. Most interestingly the biodistribution was significantly different from other clinically approved LNPs, with increased targeting to the lung. Further studies are now required to expand the possible applications of these new molecules.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Polyplus, 75 rue Marguerite Perey, 67400 Illkirch-Graffenstaden, France.
- Polyplus, 75 rue Marguerite Perey, 67400 Illkirch-Graffenstaden, France. Electronic address: mhellal@polyplus-transfection.com.
Zitieren
APA
Guéguen, C., Ben Chimol, T., Briand, M., Renaud, K., Seiler, M., Ziesel, M., Erbacher, P., & Hellal, M. (2024). Evaluating how cationic lipid affects mRNA-LNP physical properties and biodistribution. European Journal of Pharmaceutics and Biopharmaceutics, 195, 114077. https://doi.org/10.1016/j.ejpb.2023.08.002
Vancouver
Guéguen C, Ben Chimol T, Briand M, Renaud K, Seiler M, Ziesel M, et al. Evaluating how cationic lipid affects mRNA-LNP physical properties and biodistribution. European Journal of Pharmaceutics and Biopharmaceutics. 2024;195:114077. doi:10.1016/j.ejpb.2023.08.002
BibTeX
@article{Guguen2024,
author = {Guéguen, Claire and Ben Chimol, Thibaut and Briand, Margaux and Renaud, Kassandra and Seiler, Mélodie and Ziesel, Morgane and Erbacher, Patrick and Hellal, Malik},
title = {Evaluating how cationic lipid affects mRNA-LNP physical properties and biodistribution},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2024},
volume = {195},
pages = {114077},
doi = {10.1016/j.ejpb.2023.08.002}
}
EUVIMED